---
title: "European stocks \"Eleven Arhats\" | AstraZeneca closed up over 5.9%, Novo Nordisk and L'Oréal rose over 2%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/227410292.md"
description: "On Thursday (February 6), AstraZeneca's stock price rose by 5.93%, Novo Nordisk increased by 2.50%, and L'Oréal rose by 2.17%. AstraZeneca's holding company rose by 1.30%, while LVMH and SAP had the highest increase of 1.59%. Nestlé and Sanofi increased by 0.31%. GlaxoSmithKline and Novartis fell by 0.88% and Roche fell by 1.24%"
datetime: "2025-02-06T17:46:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/227410292.md)
  - [en](https://longbridge.com/en/news/227410292.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/227410292.md)
generator: "portal-rs"
---

# European stocks "Eleven Arhats" | AstraZeneca closed up over 5.9%, Novo Nordisk and L'Oréal rose over 2%

On Thursday (February 6), ASML Holding's stock price in Amsterdam (ASML.NA) rose by 1.30%, closing at €715.30.  
 Novo Nordisk's stock price in Copenhagen (NOVOB.DC) rose by 2.50%, closing at 635.00 Danish Krone.  
 AstraZeneca rose by 5.93%, L'Oréal rose by 2.17%, LVMH and SAP rose by up to 1.59%, Nestlé and Sanofi rose by up to 0.31%, while GlaxoSmithKline and Novartis fell by up to 0.88%, and Roche fell by 1.24%

### Related Stocks

- [NVO.US](https://longbridge.com/en/quote/NVO.US.md)
- [AZN.US](https://longbridge.com/en/quote/AZN.US.md)
- [LRLCY.US](https://longbridge.com/en/quote/LRLCY.US.md)
- [GSK.US](https://longbridge.com/en/quote/GSK.US.md)
- [ASML.US](https://longbridge.com/en/quote/ASML.US.md)
- [SAP.US](https://longbridge.com/en/quote/SAP.US.md)
- [NSRGY.US](https://longbridge.com/en/quote/NSRGY.US.md)
- [SNYNF.US](https://longbridge.com/en/quote/SNYNF.US.md)
- [NSRGF.US](https://longbridge.com/en/quote/NSRGF.US.md)

## Related News & Research

- [Un estudio mundial de gran relevancia revela desigualdades críticas en el acceso a la atención dermatológica](https://longbridge.com/en/news/299181972.md)
- [Novo Nordisk's hemophilia drug clears a key hurdle in Europe](https://longbridge.com/en/news/299356317.md)
- [Novo Nordisk sets 2030 ambitions, targets >DKK150B pipeline sales by 2035](https://longbridge.com/en/news/299611796.md)
- [Anthropic Builds San Francisco Biology Lab to Advance AI Drug Development](https://longbridge.com/en/news/299445995.md)
- [AstraZeneca: SERENA-4 Trial Of Etcamah Palbociclib Combination Fails To Meet Primary Objective](https://longbridge.com/en/news/298875452.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**